Temisis Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
1
Temisis Therapeutics General Information
Description
Operator of a pre-clinical biotechnology company intended to focus on the development of novel and efficacious compounds. The company's proprietary and novel small-molecule pre-clinical programs have shown efficacy, orally and topically, to remit psoriasis symptoms but without the common side effects associated with existing treatments, thereby enabling its clients the treatment of inflammatory diseases with unmet needs.
Contact Information
Website
www.temisis.comCorporate Office
- 19 Avenue De La Foret De Haye
- 54500 Vandeouvre-Les-Nancy
- France
Corporate Office
- 19 Avenue De La Foret De Haye
- 54500 Vandeouvre-Les-Nancy
- France
Temisis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Temisis Therapeutics Patents
Temisis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-6945618-B2 | Amide derivative of polycafe oil quinic acid, its production method and its use | Inactive | 26-Apr-2016 | ||
| JP-2019515036-A | Amide derivative of polycaffeoylquinic acid, process for its preparation and its use | Active | 26-Apr-2016 | ||
| AU-2017256698-A1 | Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof | Active | 26-Apr-2016 | ||
| AU-2017256698-B2 | Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof | Inactive | 26-Apr-2016 | ||
| CA-3060365-A1 | Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof | Pending | 26-Apr-2016 | C07C235/40 |
Temisis Therapeutics Signals
Temisis Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Temisis Therapeutics FAQs
-
When was Temisis Therapeutics founded?
Temisis Therapeutics was founded in 2017.
-
Where is Temisis Therapeutics headquartered?
Temisis Therapeutics is headquartered in Vandeouvre-Les-Nancy, France.
-
What is the size of Temisis Therapeutics?
Temisis Therapeutics has 3 total employees.
-
What industry is Temisis Therapeutics in?
Temisis Therapeutics’s primary industry is Drug Discovery.
-
Is Temisis Therapeutics a private or public company?
Temisis Therapeutics is a Private company.
-
What is the current valuation of Temisis Therapeutics?
The current valuation of Temisis Therapeutics is .
-
What is Temisis Therapeutics’s current revenue?
The current revenue for Temisis Therapeutics is .
-
Who are Temisis Therapeutics’s investors?
Financiere Hoche Bains and Plant Advanced Technologies PAT have invested in Temisis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process